Biotechnological Approaches to Optimize the Production of Amaryllidaceae Alkaloids
Overview
Molecular Biology
Authors
Affiliations
Amaryllidaceae alkaloids (AAs) are plant specialized metabolites with therapeutic properties exclusively produced by the Amaryllidaceae plant family. The two most studied representatives of the family are galanthamine, an acetylcholinesterase inhibitor used as a treatment of Alzheimer's disease, and lycorine, displaying potent in vitro and in vivo cytotoxic and antiviral properties. Unfortunately, the variable level of AAs' production restricts most of the pharmaceutical applications. Several biotechnological alternatives, such as in vitro culture or synthetic biology, are being developed to enhance the production and fulfil the increasing demand for these AAs plant-derived drugs. In this review, current biotechnological approaches to produce different types of bioactive AAs are discussed.
Histochemical Localization and Cytotoxic Potential of Alkaloids in .
Trujillo Chacon L, Leiva H, Rojas J, Zapata Vahos I, Castro D, Dominguez M Plants (Basel). 2024; 13(22).
PMID: 39599460 PMC: 11598390. DOI: 10.3390/plants13223251.
Navigating Amaryllidaceae alkaloids: bridging gaps and charting biosynthetic territories.
Liyanage N, Awwad F, Dos Santos K, Jayawardena T, Merindol N, Desgagne-Penix I J Exp Bot. 2024; 76(1):16-34.
PMID: 38652148 PMC: 11659181. DOI: 10.1093/jxb/erae187.
Dewes Neto B, Gomes-Copeland K, Silveira D, Gomes S, Craesmeyer J, de Castro Nizio D Plants (Basel). 2024; 13(5).
PMID: 38475416 PMC: 10935178. DOI: 10.3390/plants13050569.
Genome-scale acting catabolite-responsive element editing confers LG3145 plant-beneficial functions.
Bi M, Li M, Wei J, Meng Z, Wang Z, Ying M iScience. 2024; 27(2):108983.
PMID: 38357660 PMC: 10864199. DOI: 10.1016/j.isci.2024.108983.
Moranska E, Simlat M, Warchol M, Skrzypek E, Waligorski P, Laurain-Mattar D Molecules. 2023; 28(4).
PMID: 36838512 PMC: 9958804. DOI: 10.3390/molecules28041525.